EisaiEisai Glossary Eisai Glossary

 Eisai product names 
Generic name: eslicarbazepine acetate. Approved by the European Commission in April 2009 as an adjunctive therapy for adult patients with partial-onset seizures (including patients with secondary generalization). It is a novel, once-daily antiepileptic drug developed by Bial-Portela & Ca, S.A. and is believed to exert its antiepileptic effect by regulating activity of sodium channels. Eisai Europe Ltd. possesses the marketing rights to the product in Europe.


Copyright (C) Eisai Co., Ltd. All Rights Reserved.